Related Experiment Video
Updated: May 16, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Cardiac troponin I in congenital heart defects with pressure or volume overload
Anneli Eerola1, Eero O Jokinen, Tanja I Savukoski
1Department of Pediatrics, Tampere University Hospital, Tampere, Finland. anneli.eerola@fi mnet.fi
Insights
Cardiac troponin I (cTnI) release is more common in children with pressure overload congenital heart defects than volume overload. This cardiac biomarker elevation typically resolves after treatment.
Area of Science:
- Pediatric Cardiology
- Biomarkers in Congenital Heart Disease
Background:
- Congenital heart defects (CHDs) can lead to volume or pressure overload.
- Cardiac troponin I (cTnI) is a marker of myocardial injury.
- Autoantibodies to cTn may play a role in cardiac conditions.
Purpose of the Study:
- To determine the prevalence of cTnI and anti-cTn autoantibodies in children with CHDs causing overload.
- To compare cTnI levels in children with pressure overload versus volume overload CHDs.
- To assess changes in cTnI after treatment for CHDs.
Main Methods:
- Study included 78 children with volume overload CHDs, 60 with pressure overload CHDs, and 74 healthy controls.
- Serum levels of natriuretic peptides, cTnI, and anti-cTn autoantibodies were measured at baseline and 6 months post-treatment.
- Analysis compared baseline characteristics and outcomes between groups.
Main Results:
- Baseline cTnI was positive in 1 child (volume overload), 12 children (pressure overload), and 1 control.
- Children with positive cTnI and pressure overload were younger, had higher natriuretic peptides, and greater pressure gradients.
- Post-treatment, 63 of 64 children showed negative cTnI levels.
Conclusions:
- Pressure overload in CHDs is more strongly associated with cTnI release than volume overload.
- cTnI elevation in these pediatric patients is generally transient and resolves post-intervention.
- cTnI may serve as a useful biomarker for assessing the impact of pressure overload in CHDs.
Objective:
To evaluate the prevalence of cardiac troponin I (cTnI) and autoantibodies to cTn in children with congenital heart defects with volume or pressure overload fulfilling the criteria for treatment, and in healthy children.
Design:
The study groups comprised 78 children with volume overload caused by an atrial septal defect or a patent ductus arteriosus, and 60 children with pressure overload caused by coarctation of the aorta or stenosis of the aortic or the pulmonary valve, and 74 healthy controls. Serum levels of natriuretic peptides, cTnI, and autoantibodies to cTn were analyzed at baseline, prior to treatment and in 64 patients 6 months after treatment.
Results:
At baseline, one child with volume overload, 12 children with pressure overload, and one healthy control had positive cTnI. Further analysis of the pressure overload subgroup revealed that the children with positive cTnI were younger than those with negative cTnI, and had higher levels of natriuretic peptides. The pressure gradient at the coarctation site or stenotic valve was higher in those with positive TnI. Six months after treatment, 63 of 64 children examined were cTnI negative.
Conclusions:
The cTnI release is more frequently associated with pressure than volume overload which resolves after treatment in most children.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
